NNVC logo

NanoViricides (NNVC) Operating Profit

Annual Operating Profit

-$8.52 M
+$427.40 K+4.78%

June 30, 2024


Summary


Performance

NNVC Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNNVCprofitabilitymetrics:

Quarterly Operating Profit

-$3.17 M
-$776.40 K-32.47%

September 1, 2024


Summary


Performance

NNVC Quarterly Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNNVCprofitabilitymetrics:

TTM Operating Profit

-$9.65 M
-$1.14 M-13.34%

September 1, 2024


Summary


Performance

NNVC TTM Operating Profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNNVCprofitabilitymetrics:

Operating Profit Formula

Operating Profit = Gross Profit − Operating Expenses

NNVC Operating Profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.8%-66.0%+1.5%
3 y3 years+2.6%+13.8%-7.9%
5 y5 years+1.7%+13.8%-7.9%

NNVC Operating Profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-5.0%+4.8%-95.3%+13.8%-37.2%+1.5%
5 y5-year-6.5%+4.8%-95.3%+13.8%-37.2%+1.5%
alltimeall time<-9999.0%+11.3%-681.8%+16.5%-1334.2%+2.0%

NanoViricides Operating Profit History

DateAnnualQuarterlyTTM
Sep 2024
-
-$3.17 M(+32.5%)
-$9.65 M(+13.3%)
Jun 2024
-$8.52 M(-4.8%)
-$2.39 M(+25.3%)
-$8.52 M(-13.1%)
Mar 2024
-
-$1.91 M(-12.7%)
-$9.80 M(+1.0%)
Dec 2023
-
-$2.18 M(+7.5%)
-$9.70 M(+3.8%)
Sep 2023
-
-$2.03 M(-44.7%)
-$9.35 M(+4.6%)
Jun 2023
-$8.94 M(+10.2%)
-$3.68 M(+103.0%)
-$8.94 M(+26.7%)
Mar 2023
-
-$1.81 M(-1.3%)
-$7.06 M(+0.3%)
Dec 2022
-
-$1.83 M(+13.0%)
-$7.04 M(-1.2%)
Sep 2022
-
-$1.62 M(-9.5%)
-$7.12 M(-12.2%)
Jun 2022
-$8.11 M(-7.2%)
-$1.79 M(+0.3%)
-$8.11 M(-3.4%)
Mar 2022
-
-$1.79 M(-6.9%)
-$8.40 M(-3.7%)
Dec 2021
-
-$1.92 M(-26.5%)
-$8.71 M(-4.1%)
Sep 2021
-
-$2.61 M(+25.9%)
-$9.09 M(+3.9%)
Jun 2021
-$8.74 M(+9.3%)
-$2.07 M(-1.6%)
-$8.74 M(+2.9%)
Mar 2021
-
-$2.11 M(-8.0%)
-$8.50 M(-4.9%)
Dec 2020
-
-$2.29 M(+0.9%)
-$8.94 M(+7.9%)
Sep 2020
-
-$2.27 M(+23.9%)
-$8.28 M(+3.5%)
Jun 2020
-$8.00 M(-7.7%)
-$1.83 M(-27.9%)
-$8.00 M(-4.0%)
Mar 2020
-
-$2.54 M(+55.6%)
-$8.33 M(+5.8%)
Dec 2019
-
-$1.63 M(-17.8%)
-$7.87 M(-8.5%)
Sep 2019
-
-$1.99 M(-8.3%)
-$8.61 M(-0.6%)
Jun 2019
-$8.66 M(-7.1%)
-$2.17 M(+4.1%)
-$8.66 M(-1.3%)
Mar 2019
-
-$2.08 M(-12.1%)
-$8.77 M(-3.7%)
Dec 2018
-
-$2.37 M(+16.2%)
-$9.11 M(-0.3%)
Sep 2018
-
-$2.04 M(-10.7%)
-$9.13 M(-2.1%)
Jun 2018
-$9.33 M(-2.9%)
-$2.28 M(-5.6%)
-$9.33 M(+0.4%)
Mar 2018
-
-$2.42 M(+1.0%)
-$9.29 M(-2.1%)
Dec 2017
-
-$2.39 M(+7.3%)
-$9.49 M(+1.0%)
Sep 2017
-
-$2.23 M(-0.7%)
-$9.39 M(-2.2%)
Jun 2017
-$9.60 M(+8.4%)
-$2.25 M(-14.1%)
-$9.60 M(-2.5%)
Mar 2017
-
-$2.62 M(+13.8%)
-$9.85 M(+6.1%)
Dec 2016
-
-$2.30 M(-5.9%)
-$9.28 M(+2.3%)
Sep 2016
-
-$2.44 M(-2.2%)
-$9.07 M(+2.4%)
Jun 2016
-$8.86 M(+25.4%)
-$2.50 M(+21.9%)
-$8.86 M(-1.2%)
Mar 2016
-
-$2.05 M(-2.0%)
-$8.97 M(+11.5%)
Dec 2015
-
-$2.09 M(-6.1%)
-$8.04 M(+5.0%)
Sep 2015
-
-$2.23 M(-14.5%)
-$7.65 M(+7.6%)
DateAnnualQuarterlyTTM
Jun 2015
-$7.06 M(-18.5%)
-$2.60 M(+131.8%)
-$7.12 M(-14.3%)
Mar 2015
-
-$1.12 M(-34.1%)
-$8.31 M(-1.3%)
Dec 2014
-
-$1.70 M(+1.0%)
-$8.42 M(-0.6%)
Sep 2014
-
-$1.69 M(-55.5%)
-$8.47 M(-2.3%)
Jun 2014
-$8.67 M(+31.5%)
-$3.79 M(+207.6%)
-$8.67 M(+34.7%)
Mar 2014
-
-$1.23 M(-29.6%)
-$6.44 M(-12.9%)
Dec 2013
-
-$1.75 M(-7.3%)
-$7.39 M(+7.4%)
Sep 2013
-
-$1.89 M(+20.9%)
-$6.89 M(+4.5%)
Jun 2013
-$6.59 M(+8.4%)
-$1.56 M(-28.7%)
-$6.59 M(+0.2%)
Mar 2013
-
-$2.19 M(+76.1%)
-$6.57 M(+1.8%)
Dec 2012
-
-$1.24 M(-21.8%)
-$6.46 M(-1.4%)
Sep 2012
-
-$1.59 M(+2.8%)
-$6.55 M(+7.4%)
Jun 2012
-$6.08 M(-5.4%)
-$1.55 M(-25.5%)
-$6.10 M(+4.9%)
Mar 2012
-
-$2.08 M(+55.3%)
-$5.82 M(-7.6%)
Dec 2011
-
-$1.34 M(+17.2%)
-$6.30 M(-2.5%)
Sep 2011
-
-$1.14 M(-9.6%)
-$6.46 M(+0.5%)
Jun 2011
-$6.43 M(+30.2%)
-$1.26 M(-50.7%)
-$6.43 M(+6.7%)
Mar 2011
-
-$2.56 M(+70.6%)
-$6.02 M(+2.3%)
Dec 2010
-
-$1.50 M(+34.9%)
-$5.89 M(+10.8%)
Sep 2010
-
-$1.11 M(+29.8%)
-$5.32 M(+7.7%)
Jun 2010
-$4.94 M(+75.2%)
-$856.20 K(-64.7%)
-$4.94 M(+4.9%)
Mar 2010
-
-$2.43 M(+161.7%)
-$4.71 M(+53.1%)
Dec 2009
-
-$926.60 K(+26.6%)
-$3.08 M(+10.1%)
Sep 2009
-
-$732.10 K(+16.9%)
-$2.79 M(-0.9%)
Jun 2009
-$2.82 M(+1.0%)
-$626.40 K(-20.9%)
-$2.82 M(-11.7%)
Mar 2009
-
-$792.00 K(+22.9%)
-$3.19 M(-0.4%)
Dec 2008
-
-$644.50 K(-14.8%)
-$3.21 M(+8.1%)
Sep 2008
-
-$756.80 K(-24.2%)
-$2.97 M(+6.2%)
Jun 2008
-$2.79 M(-9.4%)
-$998.90 K(+24.0%)
-$2.79 M(+8.7%)
Mar 2008
-
-$805.30 K(+98.7%)
-$2.57 M(-4.6%)
Dec 2007
-
-$405.20 K(-30.4%)
-$2.69 M(-10.1%)
Sep 2007
-
-$582.60 K(-24.8%)
-$2.99 M(-2.9%)
Jun 2007
-$3.08 M(+18.8%)
-$774.90 K(-16.5%)
-$3.08 M(+33.6%)
Mar 2007
-
-$928.40 K(+31.4%)
-$2.31 M(+67.3%)
Dec 2006
-
-$706.60 K(+5.0%)
-$1.38 M(+105.0%)
Sep 2006
-
-$673.00 K
-$673.00 K
Jun 2006
-$2.60 M(+3833.0%)
-
-
Jun 2005
-$66.00 K
-
-

FAQ

  • What is NanoViricides annual operating income?
  • What is the all time high annual operating profit for NanoViricides?
  • What is NanoViricides annual operating profit year-on-year change?
  • What is NanoViricides quarterly operating income?
  • What is the all time high quarterly operating profit for NanoViricides?
  • What is NanoViricides quarterly operating profit year-on-year change?
  • What is NanoViricides TTM operating income?
  • What is the all time high TTM operating profit for NanoViricides?
  • What is NanoViricides TTM operating profit year-on-year change?

What is NanoViricides annual operating income?

The current annual operating profit of NNVC is -$8.52 M

What is the all time high annual operating profit for NanoViricides?

NanoViricides all-time high annual operating income is -$66.00 K

What is NanoViricides annual operating profit year-on-year change?

Over the past year, NNVC annual operating income has changed by +$427.40 K (+4.78%)

What is NanoViricides quarterly operating income?

The current quarterly operating profit of NNVC is -$3.17 M

What is the all time high quarterly operating profit for NanoViricides?

NanoViricides all-time high quarterly operating income is -$405.20 K

What is NanoViricides quarterly operating profit year-on-year change?

Over the past year, NNVC quarterly operating income has changed by -$1.26 M (-65.99%)

What is NanoViricides TTM operating income?

The current TTM operating profit of NNVC is -$9.65 M

What is the all time high TTM operating profit for NanoViricides?

NanoViricides all-time high TTM operating income is -$673.00 K

What is NanoViricides TTM operating profit year-on-year change?

Over the past year, NNVC TTM operating income has changed by +$148.80 K (+1.52%)